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OBJECTIVE — The purpose of this study was to determine the prevalence of diabetes, im-
paired glucose tolerance (IGT), impaired fasting glycemia (IFG), and associated risk factors in a
rural South African black community.
RESEARCH DESIGN AND METHODS — This was a cross-sectional survey conducted
by random cluster sampling of adults aged 15 years. Participants had a 75-g oral glucose
tolerance test using the 1998 World Health Organization criteria for disorders of glycemia.
RESULTS — Of 1,300 subjects selected, 1,025 subjects (815 women) participated (response
rate78.9%).Theoverallage-adjustedprevalenceofdiabeteswas3.9%,IGT4.8%,andIFG1.5%.
The prevalence was similar in men and women for diabetes (men 3.5%; women 3.9%) and IGT
(men4.6%;women4.7%)buthigherinmenforIFG(men4.0%;women0.8%).Theprevalence
ofdiabetesandIGTincreasedwithagebothinmenandwomen,withpeakprevalenceinthe55-
to 64-year age-group for diabetes and in the 65-year age-group for IGT. Of the cases of
diabetes, 84.8% were discovered during the survey. In multivariate analysis, the signiﬁcant
independent risk factors associated with diabetes included family history (odds ratio 3.5),
alcohol ingestion (2.8), waist circumference (1.1), systolic blood pressure (1.0), serum triglyc-
erides (2.3), and total cholesterol (1.8); hip circumference was protective (0.9).
CONCLUSIONS — Thereisamoderateprevalenceofdiabetesandahighprevalenceoftotal
disorders of glycemia, which suggests that this community, unlike other rural communities in
Africa, is well into an epidemic of glucose intolerance. There is a low proportion of known
diabetes and a signiﬁcant association with potentially modiﬁable risk factors.
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O
ver the past few decades, type 2 di-
abetes has emerged as an important
medical problem in sub-Saharan
Africa (SSA). Until the 1980s, the few re-
portedstudiesindicatedalowprevalence,
i.e., between 0 and 1.0% (1,2).
From recent estimates of the Interna-
tional Diabetes Federation, the largest in-
creases in prevalence of diabetes are
expected to occur in developing regions
of the world, including Africa. For Africa,
the regional prevalence of diabetes is pro-
jected to increase from 3.1% in 2007 to
3.5% in 2025, with a corresponding in-
creaseinnumbers:from10.4to18.7mil-
lion. The report also highlighted the
paucity of prevalence data for Africa (3).
Much of the available, albeit limited,
data on the epidemiology of diabetes in
Africa are those based on 1985 World
Health Organization (WHO) criteria (4).
These studies show a variable prevalence
of diabetes, with low rates (3%) in both
urbanandruralcommunitiesinWestand
East Africa, whereas moderate rates (3–
10%)arereportedinperiurbanandurban
communitiesinSouthAfrica,comparable
with rates in developed countries. The
moderate to high prevalence of IGT, es-
pecially in populations with low diabetes
prevalence, is suggestive of the early stage
of a diabetes epidemic (2,3,5).
Where examined, diabetes preva-
lenceishigherinurbanthaninruralcom-
munitiesinthesamecountryandlowerin
theindigenousAfricanpopulationthanin
migrantAsianormixed-ancestrycommu-
nities.Thereisevidenceforsigniﬁcantas-
sociation with age, family history of
diabetes, adiposity, urbanization, and
high rates of IGT with low diabetes prev-
alence and a low proportion of known
diabetes (2,5).
The three reported studies from in-
digenous population groups in South Af-
rica have shown moderate diabetes
prevalence varying from 5.3 to 8.0% (6–
8). The only reported studies from Africa
using current revised American Diabetes
Association(ADA)(9)andWHO(10)cri-
teria are those from Tanzania (11) and
Ghana (12). To date, there are no studies
reported in rural communities in South
Africaandnone,eitherurbanorrural,us-
ing the current criteria. This study was
undertaken to determine the prevalence
of diabetes and associated risk factors in a
rural South African community of Zulu
descent using 1998 WHO criteria for dis-
orders of glycemia.
RESEARCH DESIGN AND
METHODS—This was a cross-sec-
tional study of individuals aged 15
years, undertaken over a 3-month period
in a rural African (black) community of
Zulu descent in the Ubombo district of
the province of KwaZulu-Natal in South
Africa.
Background
With use of the 1996 population census
for South Africa, Africans constitute
76.7% (31,127,631) of the total popula-
tionof40.5million.KwaZulu-Natalisthe
most densely populated province, ac-
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total population (8,417,021). Of these,
81.7% are African, there is a female pre-
ponderance(53.1%),and56.9%arenon-
urban.
The study was done in the Ubombo
district of rural northern KwaZulu-Natal,
which has an estimated population of
487,144 (241,639 aged 15 years). The
study region is predominantly rural.
The estimated sample size based on
population size, expected maximum
prevalence (9.0%), precision (2.5%), and
conﬁdence (95%) was 1,003. When ad-
justed for a 30% nonresponse, the esti-
mated sample size was 1,300.
Survey design
Using the geographic information system
that was set up for a Malaria Control Pro-
gramme in the region, a radius of 10 km
with a regional hospital in Mkhuze as the
center was chosen as the area to be stud-
iedandincludedthedistrictsofMamfene,
Ntshange, and Orphansi. The approval of
the local health authority and tribal lead-
ers was obtained for the study.
The study was conducted by cluster
sampling of households chosen at ran-
dom from the geographic information
system map by an independent individ-
ual. Before the test day, all chosen home-
steads were visited by trained ﬁeld
workerswhosoughtthepermissionofthe
head of the household to study all non-
pregnantadultfamilymembersaged15
years including subjects known to have
diabetes.
Thestudywasconductedeitherinthe
subjects’ own homes or at a central site,
usually a community center. A nonre-
sponderwasdeﬁnedasonewhohadbeen
contacted on at least three occasions. In-
formed consent was obtained from all
participants, and the University of Kwa-
Zulu-Natal Ethics Committee approved
the study.
Survey procedure
The survey methodology was based on
the WHO ﬁeld guide for diabetes and
noncommunicable risk factor studies
(13). On the test day, all consenting sub-
jectsprovidedinformationforaquestion-
naire and had an anthropometric
examination and a 75-g oral glucose tol-
erance test (OGTT).
Questionnaire information was ob-
tained by trained interviewers in the local
languageandincludedsociodemographic
details, history and duration of urban liv-
ing, family history of diabetes in ﬁrst-
degreerelatives,personalmedicalhistory,
obstetric history where applicable, and
personalhabits(smoking,currentalcohol
consumption, and physical activity). Oc-
cupational physical activity was deﬁned
as sedentary, light, moderate, or heavy
and leisure physical activity as never, 1
time/week, 1–2 times/week, and 3
times/week.
Weight and height were measured, in
subjects wearing light clothing and with-
out shoes, for determination of BMI.
Waist circumference and hip circumfer-
ence were also measured. Blood pressure
was measured twice, in the sitting posi-
tion, using a mercury sphygmomanome-
ter; the mean of two readings, at least 30
min apart, was used. BMI was used as a
measure of total body obesity, and waist
circumference and waist-to-hip ratio
(WHR) were used as measures of upper
body (abdominal) obesity (14). Hyper-
tension was deﬁned as systolic blood
pressure 140 mmHg and/or diastolic
blood pressure 90 mmHg.
FortheOGTT(4),venousbloodsam-
ples were drawn after an overnight fast
and 2 h after ingestion of 75 g glucose
monohydrate dissolved in 250 ml water
for measurement of plasma glucose. In
addition, fasting samples were obtained
forserumlipidsanduricacid.Bloodsam-
ples were kept on ice and centrifuged
within 6 h, separated, and stored at
30°C until determination.
Biochemical methods
Plasma glucose was measured by a glu-
cose oxidase method; serum total choles-
terol, HDL cholesterol, total triglycerides,
and uric acid were measured by an enzy-
matic calorimetric method with kits
(monotest cholesterol CHOD-PAP, peri-
dochrome, and uric acid) from Boehr-
inger Mannheim (Mannheim, Germany).
LDL cholesterol was calculated by the
Friedewald formula.
OGTT classiﬁcation
Onthebasisofthe1998WHOcriteriafor
a 75-g OGTT (10), normoglycemia is de-
ﬁned by fasting plasma glucose (FPG)
6.1 mmol/l or 2-h postload plasma glu-
cose (2-h plasma glucose) 7.8 mmol/l
or both, impaired fasting glycemia (IFG)
is deﬁned by FPG 6.1–7.0 mmol/l
and (if measured) 2-h plasma glucose
7.8 mmol/l, impaired glucose tolerance
(IGT) is deﬁned by 2-h plasma glucose
7.8to11.1mmol/land(ifmeasured)
FPG 7.0 mmol/l, and diabetes is diag-
nosed by FPG 7.0 mmol/l and/or 2-h
plasma glucose 11.1 mmol/l. For com-
parison with other studies, the 1985
WHO (4), 1997 ADA (9), and 2003 ADA
(15) criteria were also applied to the
OGTT results.
Statistical analysis
Statistical analysis was performed with
SAS (version 6.12; SAS Institute, Cary,
NC) and SPSS (version 11.5; SPSS, Chi-
cago, IL). Numerical variables are ex-
pressed as means  SD. When more than
two groups were being compared,
ANOVA was used; Scheffe’s multiple-
range test was used to evaluate the differ-
ence between any two groups studied.
When only two groups were compared,
Student’s t test was used. The 
2 test was
used for categorical variables. A test was
considered signiﬁcant if P  0.05.
For prevalence estimates, the 1998
WHO criteria were applied to all subjects
who had both FPG and 2-h plasma glu-
cose data or only a classiﬁable FPG (6.1
mmol/l) result; all further intergroup
analyses were undertaken on these sub-
jects. The 1985 WHO criteria were ap-
plied to the results of subjects who had
both FPG and 2-h plasma glucose data or
only a classiﬁable FPG (7.8 mmol/l) re-
sult. The 1997 and 2003 ADA criteria
were applied to all subjects who had FPG
results available. The age-standardized
prevalence rates were calculated with the
direct method, using the world popula-
tion as the standard (16).
To assess risk factors associated with
diabetes,inbivariateanalysis,clinicaland
biochemical variables were compared in
the group with diabetes and the group
without diabetes (normoglycemia plus
IFGplusIGT)usingStudent’sttestora
2
test; in multivariate analysis, a binary lo-
gistic regression model was used with a
backward elimination method based on
likelihood ratios. Odds ratio (ORs) with
95%CIandPvaluesoftheﬁnalmodelare
presented.
RESULTS
Response rate
Of 1,300 subjects selected, 1,025 sub-
jects (210 men and 815 women) partici-
pated in the survey, with an overall re-
sponse rate of 78.9%; of these, 4 subjects,
all women, had only demographic and
anthropometric information available. Of
the 275 nonresponders, 193 (70%) were
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analysis included 1,021 subjects (210
men and 811 women). The 1998 WHO
criteria were applied to 999 subjects (799
women), the 1985 WHO criteria to 994
subjects (797 women), and the 1997/
2003 ADA criteria to 1,021 subjects (811
women).
Prevalence
With use of 1998 WHO criteria (n 
999),thecrudeoverallprevalenceofdi-
abetes was 4.6%, IGT 6.4%, IFG 1.6%,
and total disorders of glycemia 12.6%
(Table 1). The prevalence was similar in
men and women for diabetes and IGT,
whereas there was a male preponder-
ance for IFG. Using age-speciﬁc rates,
the prevalence of diabetes increased
with age in both men and women; peak
prevalence was in the 55- to 64-year
age-group. The prevalence of IGT also
increasedwithagewithpeakprevalence
in the oldest age-group (65 years). Of
the 46 subjects classed as having diabe-
tes, in 39 (84.8%) diabetes was discov-
ered during the survey. The age-
adjusted prevalence was lower for
diabetes (3.9%) and IGT (4.8%) but not
for IFG (1.5%).
Using 1985 WHO criteria (n  994),
the crude overall prevalence of diabetes
was 4.2% and IGT 6.7%. The prevalence
was similar in men and women for diabe-
tes (men 4.1%; women 4.3%), whereas
there was a male preponderance for IGT
(men 7.1%; women 6.5%). The age-
adjusted prevalence was lower for diabe-
tes (all 3.5%; men 3.0%; women 3.6%)
and for IGT (all 4.9%; men 5.6%; women
4.5%).
Using 1997 and 2003 ADA criteria
(n1,021),theoverallprevalence(crude
[adjusted])ofdiabeteswas3.1%(2.53%).
IFG prevalence was higher using 2003
ADA criteria (7.8% [7.0%]) than using
1997 criteria (2.8% [2.6%]).
Clinical and biochemical
characteristics
Table 2 shows the characteristics of the
total study group (n  1,025) and the
four glycemic categories using 1998
WHOcriteria(n999).Inthetotalstudy
group, sex comparison (women versus
men) showed that women had higher
mean values than men for the following
variables: BMI (25.9  6.5 vs. 22.8  6.8
kg/m
2, P  0.001), waist circumference
(86.0  13.5 vs. 83.3  12.2 cm, P 
0.01), and hip circumference (102.0 
13.6vs.95.711.2cm,P0.001).The
prevalence of total body adiposity (47.1
vs. 22.1%, P  0.001), increased waist
circumference (62.8 vs. 19.3%, P 
0.001), and increased WHR (45.7 vs.
1.9%, P  0.001) was also higher in
women,whereastheprevalenceofhyper-
tension was higher in men (25.0 vs.
32.2%, P  0.05). A history of urban
living(21.0vs.39.6%,P0.001),smok-
ing (10.0 vs. 22.5%, P  0.001), and al-
cohol consumption (8.6 vs. 33.5%, P 
0.001) was more frequent in men, as was
the mean WHR (0.87  0.07 vs. 0.84 
0.07, P  0.001).
Regarding the four glycemic catego-
ries (n  999), when compared with the
normoglycemia group, subjects with dia-
betesandIGTweresigniﬁcantlyolderand
had a higher prevalence of hypertension,
sedentary activity, and total body and
abdominal adiposity. There was a high
prevalence of adiposity, even in the nor-
moglycemic group.
Risk factor analysis
Multivariate analysis showed that the sig-
niﬁcant independent variables (risk fac-
tors) for diabetes in the ﬁnal model
included family history of diabetes (P 
0.014, OR 3.48 [95% CI 1.29–9.43]),
history of alcohol ingestion (P  0.009,
2.79 [1.29–6.03]), waist circumference
(P  0.000, 1.1 [1.04–1.16]), systolic
blood pressure (P  0.013, 1.02 [1.00–
1.04]), serum total cholesterol (P 
0.001, 76 [26–2.46]), and serum total
triglycerides (P  0.005, 1.58 [1.15–
2.17]); hip circumference was a protec-
tivefactor(P0.004,0.92[0.87–0.97]).
Age,BMI,WHR,anddiastolicbloodpres-
sure, although signiﬁcant in bivariate
analysis, failed to achieve signiﬁcance in
multiple logistic regression.
CONCLUSIONS —Thisstudyinaru-
ral South African community of Zulu de-
scent using current WHO criteria has
highlighted a moderate prevalence of di-
Table 1—Age- and sex-speciﬁc and age-adjusted prevalence based on 1998 WHO criteria for
categories of glycemia
n
Category of glycemia
Normoglycemia IFG IGT Diabetes
Age-group (men  women)
15–24 years 154 149 (96.8) 4 (2.6) 1 (0.7) 0 (0.0)
25–34 years 146 138 (94.5) 0 (0.0) 4 (2.7) 4 (2.7)
35–44 years 173 156 (90.2) 2 (1.2) 9 (5.2) 6 (3.5)
45–54 years 144 122 (84.7) 3 (2.1) 8 (5.6) 11 (7.6)
55–64 years 159 129 (81.1) 2 (1.3) 14 (8.8) 14 (8.8)
65 years 221 178 (80.5) 4 (1.8) 28 (12.7) 11 (5.0)
Missing 2 1 (—) 1 (—) — —
Total crude 999 873 (87.4) 16 (1.6) 64 (6.4) 46 (4.6)
Age-adjusted — 1.5 4.8 3.9
Men (n  200)
15–24 years 46 44 (95.7) 2 (4.4) 0 (0.0) 0 (0.0)
25–34 years 20 20 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
35–44 years 22 20 (90.9) 1 (4.6) 1 (4.6) 0 (0.0)
45–54 years 31 21 (67.7) 3 (9.7) 4 (12.9) 3 (9.7)
55–64 years 29 24 (82.8) 0 (0.0) 1 (3.5) 4 (13.8)
 65 years 52 40 (76.9) 3 (5.8) 3 (13.5) 2 (3.9)
Total crude 200 169 (84.5) 9 (4.5) 13 (6.5) 9 (4.5)
Age-adjusted — 4.0 4.6 3.5
Women (n  799)
15–24 years 108 105 (97.2) 2 (1.9) 1 (0.9) 0 (0.0)
25–34 years 126 118 (93.7) 0 (0.0) 4 (3.2) 4 (3.2)
35–44 years 151 136 (90.1) 1 (0.7) 8 (5.3) 6 (4.0)
45–54 years 113 101 (89.4) 0 (0.0) 4 (3.5) 8 (7.1)
55–64 years 130 105 (80.8) 2 (1.5) 13 (10.0) 10 (7.7)
 65 years 169 138 (81.7) 1 (0.6) 21 (12.5) 9 (5.4)
Missing 2 1 (—) 1 (—) — —
Total crude 799 704 (88.1) 7 (0.9) 51 (6.4) 37 (4.6)
Age-adjusted — 0.8 4.7 3.9
Data are n (%). Total n  999.
Motala and Associates
DIABETES CARE, VOLUME 31, NUMBER 9, SEPTEMBER 2008 1785abetes and a high prevalence of total dis-
orders of glycemia. There is a signiﬁcant
association with modiﬁable risk factors.
The reported African studies using
current WHO criteria are conﬁned to
those in Tanzanians (11) and Ghanaians
(12).Theoverallprevalenceofdiabetesin
this study (3.9%) is higher than that in
rural Tanzanians (men 1.7%; women
1.1%) but lower than that in urban Tan-
zanians (men 5.9%; women 5.7%) and
compared with that in a combined group
of urban and rural Ghanaians (6.4%).
However, in the Tanzanian study, only
fasting capillary blood glucose was
sampled.
Using 1985 WHO criteria, the diabe-
tes prevalence of 3.5% in this study is
lower than that in previous studies in ur-
banSouthAfricansofZulu(5.3%),Xhosa
(8.0%), or Sesotho (6.0%) descent or in
periurban Sesothos (4.8%) but higher
than the rates reported for other rural
communities in SSA, e.g., in Mali (0.9%),
Togo (0.0%), Cameroon (0.8%), and
Tanzania (1.1%) (2,5–8,17–19). Such
ﬁndings highlight the heterogeneity
among African communities. In this
study, the prevalence of IGT (4.8%) is
higher than that of diabetes and is similar
tothatforpreviousstudiesinSouthAfrica
and the rest of SSA.
Of interest is the fact that if FPG re-
sults alone are used, the prevalence of di-
abetes would be 36% lower (2.5%) and
none of the subjects with IGT (4.8%)
would be picked up (a group that is at
increased risk for future diabetes). This
fact supports previous reports that advo-
cate retention of the OGTT for evaluation
of prevalence estimates in African popu-
lations (5).
Aninterestingobservationistheolder
peak age for diabetes prevalence. This is
comparable to global estimates for devel-
oped countries but different from esti-
mates for developing countries in which
the peak is at a younger age and supports
global predictions that the numbers of
people with diabetes in the older age-
groups will increase in developing coun-
tries, owing in part to the increase in the
aging population across the world (3).
A surprising ﬁnding is that only
15.2% of the subjects with diabetes were
known to have the disorder. This ﬁnding
isincontrasttoresultsofpreviousstudies
in urban South Africans in which 50%
were known to have diabetes and compa-
rable with ﬁndings in developed coun-
tries and was thought to reﬂect better
access to health care facilities and oppor-
tunistic screening (2,6,7). These results
suggest that there still exists a disparity in
health care access and facilities between
urban and rural areas in this country.
From available reports, the only African
studies that reported a lower proportion
Table 2—Clinical and biochemical characteristics in the total study group and when based on 1998 WHO criteria for categories of glycemia
Total
Category of glycemia
P value* Normoglycemia IFG IGT Diabetes
n 1,025 873 16 64 46
Sex (men/women) 210/815 169/704 9/7 13/51 9/37 0.04
Age (years) 46.9  18.9 45.4  18.7 48.6  21.5 59.9  16.6† 57.2  15.9† 0.001
BMI (kg/m
2) 25.2  6.1 24.95  5.9 24.98  5.4 27.96  7.3† 27.90  8.3† 0.001
Waist (cm) 85.6  13.2 84.6  12.6 87.2  16.8 94.0  15.2† 94.1  14.2† 0.001
Hip (cm) 100.7  13.1 100.2  12.9 99.4  10.5 106.6  14.7† 103.8  12.8† 0.001
Waist-to-hip ratio 0.85  0.07 0.85  0.07 0.87  0.10 0.88  0.07† 0.91  0.07† 0.001
Systolic blood pressure (mmHg) 126.3  18.4 125.3  17.9 133.8  17.5 131.4  18.9 137.7  21.5† 0.001
Diastolic blood pressure (mmHg) 80.0  11.7 79.4  11.5 82.3  11.2 83.9  12.4† 85.9  12.9† 0.001
Familial diabetes (%) 8.9 8.4 18.8 6.3 13.0 0.2
Urban living (%) 24.7 23.6 43.8 23.4 32.6 0.4
Sedentary activity (%):
Occupational 19.8 18.1 18.8 39.1 30.4 0.004
Leisure 29.5 27.7 31.3 42.2 50.0 0.003
Tobacco smoking (%) 12.5 14.2 50.0 15.6 17.4 0.001
Alcohol (%) 13.7 15.2 37.5 22.2 30.4 0.003
BMI 25 kg/m
2 (%) 42.2 39.7 43.8 63.5 60.5 0.001
Waist 94 cm (men)/80 cm (women) (%) 53.9 52.0 50.0 71.4 75.0 0.001
Waist-to-hip ratio 1.0 men/0.85 women (%) 36.7 34.6 31.3 49.2 70.5 0.001
Hypertension (%) 26.5 23.7 37.5 46.9 47.8 0.001
Plasma glucose (mmol/l)
0 min 4.9  1.6 4.6  0.6 6.4  0.3† 5.4  0.6† 9.5  4.9† 0.001
120 min 6.2  2.5 5.6  0.9 6.8  0.4† 8.7  0.8† 15.4  5.8† 0.001
Serum lipids (mmol/l)
Total cholesterol 4.1  1.1 4.0  1.0 4.5  1.4 4.3  1.1 5.0  1.2† 0.001
Total triglyceride 1.1  1.1 0.98  0.6 1.23  0.8 1.26  0.6† 1.96  1.8† 0.001
HDL cholesterol 1.23  0.39 1.22  0.4 1.30  0.5 1.23  0.4 1.33  0.5 0.3
LDL cholesterol 2.4  0.07 2.3  0.8 2.6  0.9 2.5  0.9 2.8  1.1† 0.003
Serum uric acid (mol/l) 0.27  0.07 0.27  0.07 0.32  0.09† 0.31  0.08† 0.29  0.07† 0.001
Data are means  SD unless otherwise indicated. Total study group n  1,025; n  999 for application of WHO criteria. *P values for comparison between
normoglycemia versus IFG versus IGT versus diabetes (analysis of variance or 
2 method). †Signiﬁcant difference using Scheffe’s multiple range test versus
normoglycemia.
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zanians (13.2 and 8.3%) (11,19).
Multivariate analysis showed that a
positivefamilyhistoryofdiabetes,alcohol
consumption, waist circumference, hip
circumference, systolic blood pressure,
and levels of serum total triglycerides and
total cholesterol are associated with dia-
betes. This is the ﬁrst study in Africans
that has examined serum lipids, waist cir-
cumference, and hip measurements as
risk factors. In the three other African
studiesinwhichfamilyhistorywasexam-
ined, this variable was a signiﬁcant risk
factor in two Sudanese studies (2) but not
in urban Xhosas in South Africa (7).
The ﬁnding that waist circumference
is an independent risk factor for diabetes
conﬁrms recent reports in other popula-
tions that measures of abdominal rather
than of total body adiposity (BMI) may be
a better indicator of the relationship be-
tween obesity and diabetes. Moreover,
where examined, waist circumference
and not WHR is a better correlate of vis-
ceral fat deposits (20). Previous studies in
Africans have examined WHR as a mea-
sure of abdominal adiposity; WHR was a
signiﬁcant risk factor in Tanzanians (11)
and in urban and peri-urban South Afri-
cans (7,8). To our knowledge, this is the
ﬁrst study in Africans in which waist cir-
cumferencewasexaminedasariskfactor;
clearly there is a need for further studies
in Africans to conﬁrm this ﬁnding.
There are no previous reports of the
association between hip circumference
and diabetes in Africans. The negative as-
sociation found in this study conﬁrms the
recent ﬁndings in Australians (21) and
requires further evaluation in African
populations.
The association between serum total
triglycerides and diabetes conﬁrms a re-
cent report in a Spanish community (20)
but is the ﬁrst to be reported in Africans.
Its signiﬁcance needs to be established.
The positive association between al-
cohol consumption and diabetes con-
ﬁrms recent reports in Asians, but this
ﬁnding is in contrast with several other
reports in Western populations that
showed a negative association or an in-
verse relationship (22). However, in this
study, the association with grades of
drinking was not examined.
This study conﬁrms the fact that es-
tablished risk factors such as family his-
tory, systolic blood pressure, and total
cholesterolareassociatedwithdiabetesin
South Africans and concurs with ﬁndings
in Western and other populations (3,22).
A major limitation of this study is the
overrepresentation of women, a problem
thatwasalsoencounteredintwoprevious
studies in urban South Africans in which
women constituted 70% of the survey
population (6,7). In this study, there was
a higher nonresponse rate in men, which
might be accounted for by the fact that
moremenintheeconomicallyproductive
age-group move to urban areas, whereas
women, children, and older individuals
remain in the rural areas (migrant labor
system). It is therefore possible that true
estimates are higher than those reported
in this study.
In summary, this study in a rural
South African community shows a mod-
erate prevalence of diabetes and a high
prevalence of total disorders of glycemia.
There is a low proportion of known dia-
betes and a signiﬁcant association with
potentially preventable and modiﬁable
riskfactors,whichsuggeststhatthiscom-
munity, unlike other rural communities
inSSA,iswellintoanepidemicofglucose
intolerance.
Acknowledgments— This study was par-
tially sponsored by the following: the South
African Medical Research Council, the South
African Sugar Association, Novo-Nordisk
(South Africa), and Servier Laboratories South
Africa.
We also thank the following: the commu-
nity for their cooperation, Serena van Hacht,
the ﬁeld coordinator, the ﬁeld workers, Be-
thesda Hospital staff, and Nana Ngobese for
typing the manuscript.
References
1. McLartyDG,PollittC,andSwaiABM:Di-
abetes in Africa. Diabet Med 7:670-
684,1990
2. Motala AA, Omar MA, Pirie FJ: Diabetes
inAfrica:epidemiologyoftype1andtype
2 diabetes in Africa. J Cardiovasc Risk 10:
77–83, 2003
3. International Diabetes Federation: Diabe-
tes Atlas. 3rd ed. Brussels, International
Diabetes Federation, 2006
4. WorldHealthOrganization:DiabetesMel-
litus: Report of a WHO Study Group. Ge-
neva, World Health Org., 1985 (Tech.
Rep. Ser., no. 727)
5. Levitt NS, Unwin NC, Bradshaw D,
Kitange HM, Mbanya J-CN, Mollentze
WF, Omar MAK, Motala AA, Joubert G,
MasukiG,MachibyaH:Applicationofthe
new ADA criteria for the diagnosis of
diabetes to population studies in sub-Sa-
haran Africa. Diabet Med 17: 381–385,
2000
6. Omar MAK, Seedat MA, Motala AA, Dyer
RB, Becker P: The prevalence of diabetes
mellitus and impaired glucose tolerance
in a group of urban South African blacks.
S Afr Med J 83:641–643, 1993
7. Levitt NS, Katzenellenbogen JM, Brad-
shaw D, Hoffman MN, Bonnici F: The
prevalence and identiﬁcation of risk fac-
torsforNIDDMinurbanAfricansinCape
Town, South Africa. Diabetes Care
16:601–607, 1993
8. MollentzeWF,MooreAJ,SteynAF,Jou-
bert G, Steyn K, Oosthuizen GM, Weich
DJV: Coronary heart disease risk factors
in a rural and urban Orange Free State
blackpopulation.SAfrMedJ85:90–96,
1995
9. The Expert Committee on the Diagnosis
and Classiﬁcation of Diabetes Mellitus:
Report of the Expert Committee on the
Diagnosis and Classiﬁcation of Diabetes
Mellitus. Diabetes Care 20:1183–1197,
1997
10. Alberti KGMM, Zimmet PZ, WHO Con-
sultation:Deﬁnition,diagnosisandclassi-
ﬁcation of diabetes mellitus and its
complications. Part 1: diagnosis and clas-
siﬁcation of diabetes mellitus. Provisional
reportofaWHOconsultation.DiabetMed
15: 539–553, 1998
11. Aspray TJ, Mugusi F, Rashid S, Whiting
D, Edwards R, Alberti KG, Unwin NC,
Essential Non-Communicable Disease
HealthInterventionProject:Ruralandur-
ban differences in diabetes prevalence in
Tanzania: the role of obesity, physical in-
activityandurbanliving.TransRSocTrop
Med Hyg 94:637–644, 2000
12. Amoah AG, Owusu SK, Adjei S: Diabetes
in Ghana: a community based prevalence
study in Greater Accra. Diabetes Res Clin
Pract 56:197–205, 2002
13. World Health Organization: Diabetes and
Non-Communicable Disease Risk Factor
Surveys: A Field Guide. Geneva World
Health Org., 1999 (WHO/NCD/NCS/
99--1)
14. World Health Organization: Obesity: Pre-
venting and Managing the Global Epidemic:
Report of a WHO Consultation. Geneva,
World Health Org., 2000 (Tech. Rep.
Ser., no. 894)
15. The Expert Committee on the Diagnosis
and Classiﬁcation of Diabetes Mellitus:
Follow up report on the diagnosis of dia-
betes mellitus. Diabetes Care 26:3160-
3167, 2003
16. Waterhouse I, Correa P, Muir C, Powell J:
Cancer Incidence in Five Continents. Vol.
III, Lyon, France IARC, 1976, p. 456
17. Teuscher T, Rosman JB, Baillod P, Teus-
cher A: Absence of diabetes in a rural
West African population with a high car-
bohydrate/cassava diet. Lancet 1:765-
768, 1987
18. Mbanya JC Ngogang J, Salah JN, Minkou-
lou E, Balkau B: Prevalence of NIDDM
and impaired glucose tolerance in a rural
and urban population in Cameroon. Dia-
Motala and Associates
DIABETES CARE, VOLUME 31, NUMBER 9, SEPTEMBER 2008 1787betologia 40:824–829, 1997
19. McLartyDG,SwaiABM,KitangeHM,Ma-
suki G, Mtinangi BL, Kilima PM, Makene
WJ, Chuwa LM, Alberti KGMM: Preva-
lenceofdiabetesandimpairedglucosetol-
erance in rural Tanzania. Lancet 1:871–
875, 1989
20. Boronat M, Varillas VF, Saavedra P, Su-
arez V, Bosch E, Carrillo A, Novoa FJ: Di-
abetes mellitus and impaired glucose
regulation in the Canary Islands (Spain):
prevalence and associated factors in the
adult population of Telde, Gran Canaria.
Diabet Med 23:148–155, 2006
21. Snijder MB, Zimmet PZ, Visser M, Dekker
JM, Seidell JC, Shaw JE: Independent and
opposite associations of waist and hip cir-
cumferences with diabetes, hypertension
and dyslipidemia: the AusDiab Study. Int J
Obes Relat Metab Disord 28:402–409,
2004
22. Kim SM, Lee JS, Lee J, Na JK, Han JH,
Yoon DK, Baik SH, Choi DS, Choi KM:
Prevalence of diabetes and impaired fast-
ing glucose in Korea: Korean National
HealthandNutritionSurvey2001.Diabe-
tes Care 29:226–223, 2006
Diabetes prevalence in rural South African Zulu
1788 DIABETES CARE, VOLUME 31, NUMBER 9, SEPTEMBER 2008